Skip to content

Clinical trials

Phase 3 Myeloproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 3 Country / region: United States Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20042
20051
20062
20072
20086
20091
20102
20111
20121
20131
20142
20151
20181
20192
20202
20215
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated9
Active, not recruiting7
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology4
Celgene3
Children's Oncology Group3
Fred Hutchinson Cancer Center3
Incyte Corporation3
CTI BioPharma2
Case Comprehensive Cancer Center2
PharmaEssentia2
Vanderbilt-Ingram Cancer Center2
Ariad Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders42
Primary Myelofibrosis26
Myelodysplastic Syndromes19
Leukemia18
Multiple Myeloma18
Precursor Cell Lymphoblastic Leukemia-Lymphoma18
Leukemia, Lymphocytic, Chronic, B-Cell17
Leukemia, Myeloid, Acute17
Lymphoma, Non-Hodgkin17
Burkitt Lymphoma16

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.